Navigation Links
Enbrel and Humira Remain the Mainstay for First-Line Biologic Rheumatoid Arthritis Treatment
Date:9/19/2013

progression of structural damage."

The recently published report also finds that treating rheumatologists would consider switching over half of their patients who are currently treated with Genentech's Actemra IV to the subcutaneous formulation of Actemra if it were commercially available.  Moreover, treating physicians would consider switching 22-34 percent of their patients currently treated with Orencia IV and 20-25 percent of their patients who are treated with Genentech/Biogen Idec's Rituxan or Janssen Biotech's Simponi to subcutaneous Actemra, Incyte/Eli Lilly's baricitinib, Sanofi/Regeneron's sarilumab or GlaxoSmithKline/Janssen Biotech's sirukumab, if these agents were on the market.

ChartTrends®: Rheumatoid Arthritis (US) is a quantitative publication based on patient audit data collected from 983 biologic- or Xeljanz-treated RA patient charts provided by 217 rheumatologists in May - June 2013 in the United States. Through an in-depth review of specific patient charts, details such as product dosing and titration, switching, concomitant medications and a host of laboratory and patient demographic variables help define patient types and identify therapy triggers. Requirements for the patient charts include: at least 18 years of age and less than 90 years of age, currently on one of the FDA-approved biologic agents for RA or Xeljanz, and under the rheumatologist's personal management for at least six months. All collection methods were designed in compliance with HIPAA.

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at ww
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. EnbrelĀ® (etanercept) Patent Issued
2. Pittcon Announces Exhibiting Schedule for Remainder of 2013
3. Despite Lucentiss Recent Expanded Label for Diabetic Macular Edema, Avastin Remains the Preferred Intravitreal Therapy for Diabetic Macular Edema in the United States
4. Pesticide-Exempt Bed Bug Spray Samples Offered to Northern California Residents as Bed Bugs Remain a Trouble in the Area
5. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
6. ARAMARK Introduces Worlds First Reusable Validated Sterile Goggle That Remains Clear When Irradiated
7. New Way to Kill Bed Bugs Discovered; Bed Bug Bully Says Use of Bed Bug Spray Remains the Better Technique to Kill the Pests
8. Mold from Sandy Remains a Problem in Rockaways; My Cleaning Products Reaches Out to Help with Its Green Mold Removal Spray
9. Carin Grings remains identified by researchers at Uppsala University
10. 91 EnTERPreneurs Enter, Nine Remain
11. Cell Therapeutics Retires Remaining Convertible Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Meet ARGUS, The World,s First Contactless Facial ... Analyze emotions and predict actions. Explore a New Generation ... Responsive-RPG: "The Eye: Genesis".      (Photo: ... https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 Imagine being ... - and those of others. Being able to read ...
(Date:6/2/2015)... 2, 2015   Hospira, Inc. (NYSE: ... that its partner, Celltrion – a global biopharmaceutical company – ... Surveillance Agency in Brazil – ... for use in Brazil . The ... and sells biosimilar infliximab in 26 European countries and ...
(Date:6/2/2015)... 2, 2015   BioClinica ® , Inc., ... announced that David Peters , an accomplished senior ... President and Chief Financial Officer (CFO) and will be ... brings more than 25 years of financial and accounting ... extensive and deep knowledge in all areas of finance, ...
(Date:6/2/2015)... June 2, 2015  RXi Pharmaceuticals Corporation ... focused on discovering and developing innovative therapies ... ophthalmology, today announced that Dr. Pamela Pavco ... at the 23 rd World Congress ... will include in-depth presentations by world-class clinicians ...
Breaking Biology Technology:ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5BioClinica Names David Peters New Chief Financial Officer 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... Pain Management business, NATICK, Mass., Jan. 4 ... announced that it has completed the sale of,the ... pump,development program to former principals and shareholders of ... The sale,coincides with the closing of the amended ...
... YORK, Jan. 4 QED International,Associates, Inc., administrator ... indexes for the HealthShares(TM) Exchange-Traded Funds,today announced that ... January,7, 2008, Maxygen, Inc. (Nasdaq: MAXY ) ... in the HealthShares(TM) Autoimmune-Inflammation Index.,Alpharma, Inc. (NYSE: ...
... ARLINGTON, Va., Jan. 4 Faced with ... suppliers are turning their attention to,opportunities in ... navigate these unfamiliar waters, leading research and,advisory ... report,examining the marketing and media preferences of ...
Cached Biology Technology:Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program 2Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program 3QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes 2Study Examines Media Preferences of Life Scientists in Applied Markets 2Study Examines Media Preferences of Life Scientists in Applied Markets 3
(Date:6/1/2015)... -- According to a new market ... (Government, Military & Defense, Healthcare, Banking & Finance, ... (Face Recognition, Fingerprint Recognition, Iris Recognition, Palm Recognition, ... Function (Contact and Non-Contact) & Geography ( ... , APAC, Row) - Global Forecast to 2020", ...
(Date:5/27/2015)... CLEVELAND , May 27, 2015 /PRNewswire/ ... in medication safety systems and image documentation ... provider of comprehensive, technologically-advanced automation solutions, is ... art integration. The Codonics® Safe Label System® ... used in conjunction with the Omnicell Anesthesia ...
(Date:5/22/2015)... CT , May 22, 2015  NXT-ID, Inc. (NASDAQ: ... June 1st, it will be ending its promotional pricing and ... . Laurence Savin , Head of Marketing ... exclusive promotional pricing until the end of May. To get ... wocketwallet.com/invite and when we open the store on June 1, ...
Breaking Biology News(10 mins):Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... economy of the cell, little bubbles called vesicles serve ... port - the cell membrane. Some of these vesicles, ... protein factory. Scientists have long believed that other, ... and proteins through an independent process. By using a ...
... A revolutionary new protein stabilisation technique has been ... Sciences Research Council (BBSRC) which could lead to 30 ... for drug development - opening up exciting possibilities in ... a vital first step in developing new drugs, but ...
... and China have gathered in Barcelona this week to report ... data from ESA and Chinese Earth observation satellites. Dragon ... of Science and Technology (MOST) of China encourages scientists ... environmental phenomena in China. ,The symposium, held in Barcelona,s World ...
Cached Biology News:Cells use import machinery to export their goods as well 2Cells use import machinery to export their goods as well 3New nanoparticles could revolutionize therapeutic drug discovery 2Europe and China watching Earth together 2
... Engine instrument is the cycler that ... thermal uniformity and swappable blocks ensure ... This rugged machine is more ... platform for new features and upgrades ...
... The Easy Cap tool provides ... seat domed double-locking caps in tubes ... has a wide end that firmly ... prevent accidental crushing when opening or ...
Peroxidase Protective Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods....
... (MSTA) slides were designed to study protein expression ... species. Tissue slices from three different species ... then be treated as a single histological slide ... hybridization. This format allows a rapid ...
Biology Products: